OA08822A - Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant. - Google Patents

Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.

Info

Publication number
OA08822A
OA08822A OA59308A OA59308A OA08822A OA 08822 A OA08822 A OA 08822A OA 59308 A OA59308 A OA 59308A OA 59308 A OA59308 A OA 59308A OA 08822 A OA08822 A OA 08822A
Authority
OA
OAPI
Prior art keywords
morpholine
pharmaceutical compositions
preparation process
compositions containing
new derivatives
Prior art date
Application number
OA59308A
Other languages
English (en)
Inventor
Regnier Gilbert
Guilloneau Claude
Lepagnol Jean
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of OA08822A publication Critical patent/OA08822A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Control For Baths (AREA)
  • Earth Drilling (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA59308A 1987-03-24 1988-03-24 Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant. OA08822A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8704047A FR2612926B1 (fr) 1987-03-24 1987-03-24 Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
OA08822A true OA08822A (fr) 1989-03-31

Family

ID=9349348

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59308A OA08822A (fr) 1987-03-24 1988-03-24 Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.

Country Status (17)

Country Link
US (1) US4782054A (fr)
EP (1) EP0286495B1 (fr)
JP (1) JPH0657709B2 (fr)
AT (1) ATE89281T1 (fr)
AU (1) AU600209B2 (fr)
CA (1) CA1313870C (fr)
DE (1) DE3880874T2 (fr)
DK (1) DK171580B1 (fr)
ES (1) ES2006390A6 (fr)
FR (1) FR2612926B1 (fr)
GR (1) GR1000241B (fr)
HK (1) HK57297A (fr)
IE (1) IE61882B1 (fr)
NZ (1) NZ223984A (fr)
OA (1) OA08822A (fr)
PT (1) PT87061B (fr)
ZA (1) ZA882107B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653999A1 (fr) * 1989-11-06 1991-05-10 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
BRPI0510453A (pt) * 2004-04-30 2007-10-30 Warner Lambert Co composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la

Also Published As

Publication number Publication date
JPH0657709B2 (ja) 1994-08-03
GR880100179A (en) 1989-01-31
ES2006390A6 (es) 1989-04-16
GR1000241B (el) 1992-05-12
DE3880874T2 (de) 1993-12-23
AU1352088A (en) 1988-09-22
DK171580B1 (da) 1997-02-03
CA1313870C (fr) 1993-02-23
FR2612926A1 (fr) 1988-09-30
JPS63255279A (ja) 1988-10-21
PT87061A (pt) 1988-04-01
EP0286495A1 (fr) 1988-10-12
ZA882107B (en) 1989-06-28
EP0286495B1 (fr) 1993-05-12
ATE89281T1 (de) 1993-05-15
AU600209B2 (en) 1990-08-02
US4782054A (en) 1988-11-01
DE3880874D1 (de) 1993-06-17
PT87061B (pt) 1992-07-31
IE61882B1 (en) 1994-11-30
IE880851L (en) 1988-09-24
NZ223984A (en) 1990-05-28
DK150088A (da) 1988-09-25
HK57297A (en) 1997-05-09
FR2612926B1 (fr) 1989-06-09
DK150088D0 (da) 1988-03-18

Similar Documents

Publication Publication Date Title
PT80661B (en) Process for preparing substituted imidazopyridines
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
JPS56167670A (en) 1-piperazino-3-phenylindane derivative, its manufacture, pharmaceutical composition and piperazine derivative for manufacture
OA08822A (fr) Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
DE3063288D1 (en) Paromomycin derivatives, a process for the preparation thereof and therapeutical composition containing them
OA08854A (fr) Nouveaux dérivés du spiro (4,5) décane, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR2703048B1 (fr) Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
OA09467A (fr) Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
OA09451A (fr) "Nouveaux dérivés de la pyrrolidone, leur procédé de préparation et les compositions pharmaceutiques les renfermant".
HUT48464A (en) Process for producing pharmaceutical composition for treating hypertonia and cardiac failure
FI891155A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi
IL85229A0 (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof
DE3680893D1 (de) Pyrimido(5,4-b)(1,4)oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b)(1,4)oxazinderivate.
FR2711651B1 (fr) Nouveaux analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
PT86422A (fr) Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant
ATE28189T1 (de) 2-alkylthio-1-aminoalkyl-2-pyrrolin-3carbonitrile, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die prophylaxe und therapie thrombotischer zustaende.